Summit Wealth & Retirement Planning, Inc. Aquestive Therapeutics, Inc. Transaction History
Summit Wealth & Retirement Planning, Inc.
- $389 Million
- Q3 2025
A detailed history of Summit Wealth & Retirement Planning, Inc. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Summit Wealth & Retirement Planning, Inc. holds 15,000 shares of AQST stock, worth $80,850. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,000
Previous 10,000
50.0%
Holding current value
$80,850
Previous $33,000
151.52%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
167Shares Held
66MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...